Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

Video

Tina Q Tan, MD, and Kimberly Simmons, MD, provide an overview of the prevalence of type 1 diabetes (T1D) in pediatric patients as well as its risk factors.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Greg Forlenza, MD
Greg Forlenza, MD
Greg Forlenza, MD
Herbert Bravo, MD
Brittany Bruggeman, MD
Brittany Bruggeman, MD
Brittany Bruggeman, MD
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Related Content
Third-trimester hyperglycemia in pregnancy linked to adult obesity in offspring | Image Credit: © lukszczepanski - stock.adobe.com.

Third-trimester hyperglycemia in pregnancy linked to adult obesity in children

Morgan Ebert, Managing Editor
June 23rd 2025
Article

A 40-year study found that higher third-trimester glucose levels in insulin-dependent pregnancies were tied to increased obesity risk in adult offspring.

Diabetes device data may fail to deliver based on smartphone settings | Image Credit: © KRISTINA KUPTSEVICH - © KRISTINA KUPTSEVICH - stock.adobe.com.

Diabetes device data may fail to deliver based on smartphone settings

Joshua Fitch, Senior Editor
February 5th 2025
Article

The FDA is warning diabetes patients that information from CGMs, insulin pumps, and automated dosing systems could fail to be delivered if smartphone settings are not properly configured.

Image Credit: © Calin - stock.adobe.com

FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up

Patrick Campbell
December 23rd 2024
Article

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial | Image Credit: © Africa Studio - © Africa Studio - stock.adobe.com.

Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial

Joshua Fitch, Senior Editor
December 20th 2024
Article

The primary endpoint was non-inferiority in HbA1c levels after 26 weeks.

Resilience programs improve behavioral outcomes in adolescents with T1D distress | Image Credit: © Alina - © Alina - stock.adobe.com.

Resilience programs improve behavioral outcomes in adolescents with T1D distress

Joshua Fitch, Senior Editor
October 16th 2024
Article

Investigators sought to test the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention on levels of HbA1c.

Image Credit: © Artur - ©Artur - stock.adobe.com.

Weekly review: Extended labels, T1D inheritance data, and more

Joshua Fitch, Senior Editor
August 2nd 2024
Article

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

© 2025 MJH Life Sciences

All rights reserved.